Evidence map›Paper›PMID 41760887›Full record

ReviewNature metabolism2026

Obesity as a catalyst for neurodegeneration.

Bandy Chen, Amanda Rodríguez-Díaz, Marc Schneeberger, Eric Topol

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bandy ChenDepartment of Medicine, UC San Diego School of Medicine, La Jolla, CA, USA. bac008@health.ucsd.edu.ORCID http://orcid.org/0009-0009-9099-1218
Amanda Rodríguez-DíazLaboratory of Neurovascular Control of Homeostasis, Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5145-4692
Marc SchneebergerLaboratory of Neurovascular Control of Homeostasis, Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA. marc.schneebergerpane@yale.edu.ORCID http://orcid.org/0000-0001-7369-104X
Eric TopolScripps Research Translational Institute, La Jolla, CA, USA. etopol@scripps.edu.

Funding

UC San Diego Medical Scientist Training ProgramT32GM154642 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Neil C Chi, Mary Kathleen Lewinski · 2025 to 2026
$2.9M
NIGMS NIH HHS T32 GM154642
6 · The paper itself

Abstract

The parallel rise in obesity and neurological disorders suggests a potential mechanistic link between these two conditions. Midlife obesity is a well-established risk factor for cognitive decline and neurological disorders; however, the underlying mechanisms and cause-and-effect relationship remain poorly defined, in part owing to limited spatiotemporal resolution in existing studies and the absence of a unifying framework. Recent studies have begun to uncover pathways linking obesity to neurodegenerative vulnerability. First, we discuss how obesity induces brain-wide reprogramming across neural, metabolic and vascular systems including neurovascular coupling, blood-brain barrier integrity, cerebrospinal fluid dynamics and myelination. By systematically examining the disparate mechanisms for each condition, a more cohesive picture emerges, revealing progressive neurodegeneration driven by chronic metabolic overload. Lastly, we propose a framework that integrates these different mechanisms with both spatial and temporal specificity.

Indexed as

Neurodegenerative DiseasesObesityAnimalsBrainHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.